Toggle light / dark theme

NASA’s Lucy mission, led by Southwest Research Institute (SwRI), has achieved an important milestone by passing its System Integration Review and clearing the way for spacecraft assembly. This NASA Discovery Program class mission will be the first to explore Jupiter’s Trojan asteroids, ancient small bodies that share an orbit with Jupiter and hold important insights to understanding the early solar system.

The Lucy spacecraft, during its nominal 12-year mission, will fly by and collect data from seven of these primitive worlds, plus a main belt asteroid. Because the Trojan asteroids are remnants of the primordial material that formed the outer planets, they hold vital clues to deciphering the history of the solar system. Lucy, like the human fossil for which it is named, will revolutionize the understanding of our origins.

Over the last few months, the Lucy team has focused on building and testing all the components of the spacecraft, including the , electronics, communications and navigation systems while observing all appropriate pandemic protocols. At this review, the Lucy team demonstrated to an independent senior review board, including NASA and external experts, that the systems and subsystems are on schedule to proceed to assembly, testing and integration.

Circa 2011


Gravity is no obstacle for this climbing robot. It scales vertical walls—even those made of smooth materials like glass. Jeff Krahn, an engineer from Simon Fraser University in British Columbia, created this gecko-inspired tank of a robot, which he detailed in a paper in the journal Smart Materials and Structures this week.

Like a gecko, which can hang on to sheer glass with just one toe, the climbing bot uses what physicists call Van der Waals forces to stick to the wall. Its tanklike tracks are covered in a dry adhesive, a polymer resembling silicon that allows adhesion without chemicals or added energy. The molecules that make up this substance are temporary dipoles; they have a positively charged side and a negatively charged side. The charged sides of the molecules are attracted to their corresponding opposites on the wall the robot is climbing: negative to positive, positive to negative. Given enough surface area for these attractions to take place, Van der Waals forces can keep a pretty substantial weight stuck to a vertical wall. The climbing bot, for example, weighs in at half a pound.

:ooooo.


What is CAR-T therapy?

CAR-T therapy involves genetically engineering patient T-cells so that they express a chimeric antigen receptor (CAR).

CARs consist of a protein that binds to cancer cells, usually an antibody, fused to the signaling domain from a T-cell receptor (TCR). The idea is that a killer T-cell expressing the CAR engages cancer cells and eliminates them.

Just recycle the hydrogen and bring to another layer in the sun :3.


Remember the movie Sunshine, where astronomers learn that the Sun is dying? So a plucky team of astronauts take a nuclear bomb to the Sun, and try to jump-start it with a massive explosion. Yeah, there’s so much wrong in that movie that I don’t know where to start. So I just won’t.

Seriously, a nuclear bomb to cure a dying Sun?

One of the reasons the SARS-CoV-2 virus is so successful u2014 and thus dangerous u2014 is that it can suppress the non-specific immune response. In addition, it lets the human cell produce the viral protein PLpro (papain-like protease). PLpro has two functions: It plays a role in the maturation and release of new viral particles, and it suppresses the development of type 1 interferons. The German and Dutch researchers have now been able to monitor these processes in cell culture experiments. Moreover, if they blocked PLpro, virus production was inhibited and the innate immune response of the human cells was strengthened at the same time.nn


COVID-19 Research: Anti-viral Strategy With Double Effect

In the case of an infection, the SARS-CoV-2 virus must overcome various defense mechanisms of the human body, including its non-specific or innate immune defense. During this process, infected body cells release messenger substances known as type 1 interferons. These attract natural killer cells, which kill the infected cells.

One of the reasons the SARS-CoV-2 virus is so successful — and thus dangerous — is that it can suppress the non-specific immune response. In addition, it lets the human cell produce the viral protein PLpro (papain-like protease). PLpro has two functions: It plays a role in the maturation and release of new viral particles, and it suppresses the development of type 1 interferons. The German and Dutch researchers have now been able to monitor these processes in cell culture experiments. Moreover, if they blocked PLpro, virus production was inhibited and the innate immune response of the human cells was strengthened at the same time.

Well, they don’t.


Thousands are currently engaged in solving the problem of death. Maybe they’ll succeed, and out of sheer boredom I’ll reread this sentence when I’m 900 years old, reflecting fondly on the first wasted century of my life. In the meantime, billions are going to die—some from disease, some in freak accidents, and a substantial number from what we generally call “old age.” That last sounds like a pleasant way to go, comparatively—a peaceful winding-down. But what exactly does it look like? What does it really mean to die from old age? For this week’s Giz Asks, we reached out to a number of experts to find out.

A disease-detecting “precision health” toilet can sense multiple signs of illness through automated urine and stool analysis, according to a new study.

The “smart toilet” isn’t the kind that lifts its own lid in preparation for use; this toilet includes technology that can detect a range of disease markers in stool and urine, including those of some cancers, such as colorectal or urologic cancers.

The device could hold particular appeal for people genetically predisposed to certain conditions, such as irritable bowel syndrome, prostate cancer, or kidney failure, and want to keep on top of their health.

February 27, 2020 — Accuray Incorporated announced that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife M6 System in Missouri at their state-of-the-art David C. Pratt Cancer Center. The next-generation CyberKnife System has been shown to deliver precise stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments with ease, making it possible for the clinical team to expand access to one of the most advanced methods for administering radiation to more cancer patients.

SRS and SBRT are non-invasive forms of radiation therapy that use high doses of very targeted radiation to destroy tumors, in just a few treatment sessions (1 to 5). SRS is commonly used to treat conditions within the brain and spine, while SBRT is used for those tumors located outside these areas. The CyberKnife M6 System is equipped with sophisticated functionality that will streamline the creation of personalized treatment plans and reduce the time to deliver radiation treatments, enabling the Mercy St. Louis team to offer precision SRS and SBRT treatments to more patients each day.

The Mercy Hospital St. Louis team uses the most advanced radiotherapy technology to design and deliver an individualized treatment plan designed to help cancer patients take control of their disease and resume their lives. The hospital is part of the Mercy system, named one of the top five large U.S. health systems from 2016 to 2019 by IBM Watson Health. Mercy announced in 2018 that it intended to work with Accuray to enhance cancer care through advanced life-saving technology, including the CyberKnife System that was recently installed as well as Accuray Radixact Systems that will be installed at other Mercy hospitals.

A study from researchers at KAIST (Korea Advanced Institute of Science and Technology) is providing new insights into a cellular energy pathway that has been linked to longer lifespan. The research, conducted in human cells and roundworms, raises the prospect of anti-aging therapeutics that can extend lifespan by activating this pathway.

AMPK (adenosine monophosphate-activated protein kinase) is an enzyme that acts as a metabolic master switch. It has been described as a “magic bullet” protein, conferring broad beneficial health effects, from improving cardiovascular health to extending lifespan. It is activated in response to low cellular energy levels, as is often seen during exercise or periods of caloric restriction.

An increasing volume of study has found activating AMPK in animal models leads to notable increases in lifespan, prompting a surge in research investigating this enzyme.

SAN CARLOS, Calif., Feb. 19, 2020 /PRNewswire/ — ZAP Surgical Systems, Inc. today announced an agreement with Bonifatius Hospital in Lingen, Germany to acquire ZAP-X® stereotactic radiosurgery (SRS) technology.

SRS is a well-known and effective procedure for non-invasively treating select brain tumors and brain metastases. However, significant acquisition and radiation shielding costs of historical SRS systems have limited widespread access to this potentially life-saving therapy. Consequently, scarce availability of SRS treatment has remained heavily concentrated in large urban hospitals.